
Pgpipn Peptide Therapy
Benefits, Side Effects, Cost & Protocols
PGPIPN is a hexapeptide derived from prolactin that has demonstrated neuroprotective properties. It protects against oxidative stress-induced neuronal damage and is studied for its potential in neurodegenerative disease prevention and cognitive preservation.
Clinically Reviewed
Reviewed by Alex Evans, PharmD, MBA · Updated May 2026
Evidence-Based
Sourced from FDA, PubMed & ClinicalTrials.gov · View sources
Who Is Pgpipn Best For?
How Pgpipn Works
Hexapeptide with immunomodulatory and anti-inflammatory properties that may help regulate inflammatory responses in damaged tissue.
Pgpipn FAQ
What is PGPIPN?
PGPIPN is a therapeutic hexapeptide (Pro-Gly-Pro-Ile-Pro-Asn) researched for its immunomodulatory and anti-inflammatory properties, particularly in chronic inflammatory conditions and tissue repair.
How does PGPIPN work?
Hexapeptide with immunomodulatory and anti-inflammatory properties that may help regulate inflammatory responses in damaged tissue.
Is PGPIPN legal to buy?
PGPIPN is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy PGPIPN?
PGPIPN is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.
What category does PGPIPN belong to?
PGPIPN is primarily classified as a tissue repair & healing peptide. Peptides studied for their potential in wound healing, tendon/ligament repair, gut healing, and general tissue regeneration.
What are the research benefits of PGPIPN?
PGPIPN has been studied for: Anti-inflammatory potential, Tissue repair support, Immunomodulation. Emerging research peptide; limited clinical data.
Key Studies
6 total on PubMed0PGPIPN, a therapeutic hexapeptide, suppressed human ovarian cancer growth by targeting BCL2
Wang W, Gu F, Wei C et al
PLoS OneAnimal
PGPIPN suppressed ovarian cancer growth in vitro and in vivo by promoting apoptosis through BCL2 pathway inhibition
The milk-derived hexapeptide PGPIPN inhibits the invasion and migration of human ovarian cancer cells by regulating the expression of MTA1 and NM23H1 genes
Zhao M, Wei C, Yang X et al
In Vitro · Int J Oncol
PGPIPN hexapeptide inhibited ovarian cancer cell invasion and migration by regulating MTA1 and NM23H1 expression
Construction of an Anticancer Fusion Peptide (ACFP) Derived from Milk Proteins and an Assay of Anti-ovarian Cancer Cells in vitro
Zhou J, Yang X, Zhang W et al
In Vitro · Anticancer Agents Med Chem
ACFP fusion peptide more effectively inhibited ovarian cancer cell viability and induced apoptosis than parent peptides
Pgpipn News
News aggregated via Google News. Inclusion does not imply endorsement.
Ready to explore Pgpipn with a provider?
Take our 2-minute quiz to get matched with a board-certified provider specializing in Pgpipn.
Take the Quiz →